ICU Medical/$ICUI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ICU Medical
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Ticker
$ICUI
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
15,000
ISIN
US44930G1076
Website
ICU Medical Metrics
BasicAdvanced
$3.3B
-
-$3.83
0.88
-
Price and volume
Market cap
$3.3B
Beta
0.88
52-week high
$181.06
52-week low
$106.22
Average daily volume
270K
Financial strength
Current ratio
2.594
Quick ratio
0.87
Long term debt to equity
74.889
Total debt to equity
77.295
Interest coverage (TTM)
1.12%
Management effectiveness
Return on assets (TTM)
1.79%
Return on equity (TTM)
-4.62%
Valuation
Price to revenue (TTM)
1.344
Price to book
1.65
Price to tangible book (TTM)
-17.77
Price to free cash flow (TTM)
26.794
Growth
Revenue change (TTM)
7.22%
Earnings per share change (TTM)
56.00%
3-year revenue growth (CAGR)
16.23%
3-year earnings per share growth (CAGR)
27.14%
What the Analysts think about ICU Medical
Analyst ratings (Buy, Hold, Sell) for ICU Medical stock.
ICU Medical Financial Performance
Revenues and expenses
ICU Medical Earnings Performance
Company profitability
ICU Medical News
AllArticlesVideos
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Accesswire·1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Accesswire·2 weeks ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI
Accesswire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ICU Medical stock?
ICU Medical (ICUI) has a market cap of $3.3B as of June 06, 2025.
What is the P/E ratio for ICU Medical stock?
The price to earnings (P/E) ratio for ICU Medical (ICUI) stock is 0 as of June 06, 2025.
Does ICU Medical stock pay dividends?
No, ICU Medical (ICUI) stock does not pay dividends to its shareholders as of June 06, 2025.
When is the next ICU Medical dividend payment date?
ICU Medical (ICUI) stock does not pay dividends to its shareholders.
What is the beta indicator for ICU Medical?
ICU Medical (ICUI) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.